Practical Guidance on Peptide Receptor Radionuclide Therapy
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 3
Abstract
Peptide receptor radionuclide therapy (PRRT) have been successfully used for the past 20 years to target metastatic or inoperable neuroendocrine tumors expressing the somatostatin receptors. Both prospective and retrospective studies indicate that patients receiving PRRT show significantly high objective responses, leading to longer survival and improved quality of life. PRRT is generally well tolerated, with acceptable hematological toxicity profiles. Nephrotoxicity is dose-limiting with Y-90 labelled peptides and not with Lu-177. The majority of centers use standard protocols based on fixed activities, at most modulating the activity or the number of administrations based on the patient clinical scenario and risk factors. This guidance covers the rationale, indications and contraindications for PRRNT, assessment of treatment response and patient follow-up. This practical guidance is aimed at guiding nuclear medicine specialists in delivering the treatment in a safe and effective manner.
Authors and Affiliations
Emre Demirci, Nalan Alan Selçuk, Levent Kabasakal, Gülin Uçmak, Umut Elboğa, Cüneyt Türkmen, İlknur Ak Sivrikoz
Keywords
Related Articles
- EP ID EP691582
- DOI 10.4274/nts.galenos.2020.0033
- Views 120
- Downloads 0
Guideline for the Treatment of Liver Cancer with Y-90 Radiomicrosphere
Yttrium-90 microsphere therapy, which has become more common in recent years, offers an effective and safe radionuclide treatment option in the treatment of primary and metastatic liver tumors. The success of the treatme...
Procedure Guideline for Scintigraphic Imaging in Cardiac Transthyretin Amyloidosis
Amyloidosis is a multisystem disease that results from extracellular deposition of amyloid fibriles in tissue and cardiac involvement may be seen. Cardiac amyloidosis is a rare and mostly underdiagnosed cause of heart fa...
Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma
Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact i...
Good Radiopharmacy Practices In Magistral (or Inhouse or Smallscale) Produced Radiopharmaceuticals
Radiopharmaceuticals differ from normal medicines in that they have a short half-life. Due to the rapid decay, they must be prepared shortly before their clinical use and comprehensive quality control of the final produc...
Acceptance Tests and Quality Control of the Positron Emission Tomography (PET) Systems
Quality control (QC) applications are important for the reliability and accuracy of the results obtained from positron emission tomography (PET) imaging systems in clinical trials. With these applications, exposure of pa...